Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Investor Presentation (May 2019)
14 slides from Narayana Hrudayalaya's investor presentation, May 24, 2019
Slide 1: Narayana Health submission letter to stock exchanges
A, Nt Narayana Health" Date of Submission: 24t.11 May 2019 To, To, The Secretary The Secretary listing Department listing Department SSE limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Sandra Kurla Complex Ph1roze Jeejeebhoy Towers, Mumbai - 400050 D
Slide 2: Investor Presentation May 2019
Investor Presentation May 2019
Slide 3: Important Disclosure
Important Disclosure No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its da
Slide 4: NH at a Glance
NH at a Glance As on 1st May 2019 NH’s footprint in India 50 Healthcare Facilities Operational beds 21 Owned / Operated Hospitals(1) 5,294 Beds Kakriyal, Jammu Northern Region 2 Managed Hospitals(2) 498 Beds 3 hospitals Operational beds: 614 7 Heart Centres 371 Beds 19 Primary Healthcare Facilities(
Slide 5: Key Highlights – Q4 FY19
Key Highlights – Q4 FY19 ▪ Narayana Institute of Cardiac Sciences, Bengaluru performed India’s first Interventional Fontan Completion, a hybrid treatment modality that reduces the number of surgeries required from 3 to 1 to treat congenital heart diseases ▪ SRCC, Mumbai now runs the 2nd largest paed
Slide 6: Revenue Mix – India Business (FY19)
Revenue Mix – India Business (FY19) Operating Revenues Business Mix INR mn 24,798 22,040 94% 5% 1% 5,698 6,514 (1) Owned / Operated Hospitals Heart Centres Q4 FY18 Q4 FY19 FY18 FY19 Other Anciliary Businesses (2) Speciality-Profile(6) Payee-Profile(3,7) Cluster-Wise(5) 12% 11% 6% 4% 14% 9% 17% 40% 4
Slide 7: Operational Review – India Business
Operational Review – India Business Operational Beds(1) Discharges(2) 259,766 237,437(3) 6,126 6,173 1st May 2018 1st May 2019 FY18 FY19 ARPOB(2) ALOS(2) INR mn Days 9.0 8.0(3) 4.2(3) 3.9 FY18 FY19 FY18 FY19 (1) Includes Managed Hospitals (2) Excludes Managed Hospitals (3) Excludes Gurugram 6
Slide 8: Operational Review – HCCI
Operational Review – HCCI ARPOB Discharges(2) US$ mn 2,527 2,166 1.7 1.6 FY18 FY19 FY18 FY19 Operating Revenues Profitability US$ mn US$ mn 54.5 EBITDA EBITDA Margin (%) 44.6 17.4% 13.5% 6.0(1) 9.5 0.0 FY18 FY19 FY18 FY19 (1) Adjusted for one-time transaction cost of US$ 0.96 Mn (2) ALOS for the per
Slide 9: Operational Review – HCCI
Operational Review – HCCI Evolving as a Multispecialty Healthcare Provider Steady Ramp-up in Occupied Beds 5% 34 19% 28% 15% 29% 4% 39% 27 28% 13% 20% 22% 17 23% 16% 80% 13% 8 49% 36% 35% 3 26% FY15 FY16 FY17 FY18 FY19 FY15 FY16 FY17 FY18 FY19 Cardiac Sciences Orthopaedics Neuro Sciences Others Reve
Slide 10: Regional Split – India Business (FY19)
Regional Split – India Business (FY19) This considers owned/operated hospitals in India (excl. Jammu) Southern Eastern Regions Bangalore Kolkata Western Delhi NCR Peripheral Peripheral % of Hospital Operating 6% 29% 5% 14% 6% 40% Revenues YoY Revenue Growth 8% 6% 9% 6% 11% 26% 79%* % of Hospital 32%
Slide 11: Maturity Profile – India Business (FY19)
Maturity Profile – India Business (FY19) This considers owned/operated hospitals in India (excl. Jammu) Maturity Hospitals (Exc. Hospital % of Hospital Key Performance Indicators(1) Managed Hospitals & Operating Revenues(1) Operational Beds(1) Jammu)(1) % of Total YoY Growth ARPOB (INR mn) Occupancy
Slide 12: Profitability Snapshot – India Business
Profitability Snapshot – India Business EBITDA and EBITDA Margin Cost Structure INR mn Movement across New Hospitals % of Operating Revenues Q4 FY19 FY19 Losses Revenues Losses Revenues 90.8% Rental / Revenue Share 91.2% SRCC 59 127 SRCC 259 453 Dharamshila 33 262 Dharamshila 96 1,003 Gurugram 67 13
Slide 13: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR mn, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR mn) Q4 FY19 FY19 Particulars 31st March 2019 Total Operating Revenue 7,652 28,609 Purchase of Medical Consumables, Drugs Shareholder Equity 10,811 1,
Slide 14: Shareholding Pattern
Shareholding Pattern Shareholding as on 31st March 2019(1) Total Number of Shares 204,360,804 ESOP Trust Others 0.8% 3.3% PE Investors 13.1%(3) CDC - 7.9% Asia Growth Capital - 5.2% FIIs / DIIs and Retail 19.0% Promoter Group FIIs - 10.0% 63.9%(2) DIIs - 4.7% Retail - 4.3% (1) Percentages might not
Narayana Hrudayalaya — Investor Presentation (May 2019) on 6ix